• 2023
  Santos da Silva E, Servais JY, Kohnen M, Arendt V, Staub T, The Con-Vince Consortium , The CoVaLux Consortium , Krüger R, Fagherazzi G, Wilmes P, Hübschen JM, Ollert M, Perez-Bercoff D, Seguin-Devaux C, Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern., Int J Mol Sci 2023 Oct; 24(19): .
• 2023
  Santos da Silva E, Servais JY, Kohnen M, Arendt V, Gilson G, Staub T, Seguin-Devaux C, Perez-Bercoff D, Vaccine- and Breakthrough Infection-Elicited Pre-Omicron Immunity More Effectively Neutralizes Omicron BA.1, BA.2, BA.4 and BA.5 Than Pre-Omicron Infection Alone., Curr Issues Mol Biol 2023 Feb; 45(2): 1741-1761.
• 2022
  da Silva ES, Kohnen M, Gilson G, Staub T, Arendt V, Hilger C, Servais JY, Charpentier E, Domingues O, Snoeck CJ, Ollert M, Seguin-Devaux C, Perez-Bercoff D, Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone., Int J Mol Sci 2022 Jul; 23(14): .
• 2021
  Hafezi F, Jaxel L, Lemaire M, Turner JD, Perez-Bercoff D, TERT Promoter Mutations Increase Sense and Antisense Transcription from the TERT Promoter., Biomedicines 2021 Nov; 9(12): .
• 2021
  Perez-Bercoff D, Laude H, Lemaire M, Hunewald O, Thiers V, Vignuzzi M, Blanc H, Poli A, Amoura Z, Caval V, Suspène R, Hafezi F, Mathian A, Vartanian JP, Wain-Hobson S, Sustained high expression of multiple APOBEC3 cytidine deaminases in systemic lupus erythematosus., Sci Rep 2021 Apr; 11(1): 7893.
• 2020
  Hafezi F, Perez Bercoff D, The Solo Play of TERT Promoter Mutations., Cells 2020 Mar; 9(3): .
• 2019
  Arendt V, Amand M, Iserentant G, Lemaire M, Masquelier C, Ndayisaba GF, Verhofstede C, Karita E, Allen S, Chevigné A, Schmit JC, Bercoff DP, Seguin-Devaux C, Predominance of the heterozygous CCR5 delta-24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR5 addressing at the cell surface., J Int AIDS Soc 2019 Sep; 22(9): e25384.
• 2018
  Beraud C, Lemaire M, Perez Bercoff D, Reassessment of the capacity of the HIV-1 Env cytoplasmic domain to trigger NF-κB activation., Virol J 2018 Feb; 15(1): 35.
• 2016
  Santos da Silva E, Mulinge M, Lemaire M, Masquelier C, Beraud C, Rybicki A, Servais JY, Iserentant G, Schmit JC, Seguin-Devaux C, Perez Bercoff D, The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell Transmission., PLoS One 2016 ; 11(9): e0161596.
• 2015
  Dauwe K, Mortier V, Schauvliege M, Van Den Heuvel A, Fransen K, Servais JY, Bercoff DP, Seguin-Devaux C, Verhofstede C, Characteristics and spread to the native population of HIV-1 non-B subtypes in two European countries with high migration rate., BMC Infect Dis 2015 Nov; 15(): 524.
• 2015
  Cashin K, Gray LR, Harvey KL, Perez-Bercoff D, Lee GQ, Sterjovski J, Roche M, Demarest JF, Drummond F, Harrigan PR, Churchill MJ, Gorry PR, Reliable genotypic tropism tests for the major HIV-1 subtypes., Sci Rep 2015 Feb; 5(): 8543.
• 2015
  Swartz JE, Vandekerckhove L, Ammerlaan H, de Vries AC, Begovac J, Bierman WF, Boucher CA, van der Ende ME, Grossman Z, Kaiser R, Levy I, Mudrikova T, Paredes R, Perez-Bercoff D, Pronk M, Richter C, Schmit JC, Vercauteren J, Zazzi M, Židovec Lepej S, De Luca A, Wensing AM, Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe., J Antimicrob Chemother 2015 ; 70(6): 1850-7.
• 2014
  Struck D, Lawyer G, Ternes AM, Schmit JC, Bercoff DP, COMET: adaptive context-based modeling for ultrafast HIV-1 subtype identification., Nucleic Acids Res 2014 Oct; 42(18): e144.
• 2014
  Szpakowska M, Perez Bercoff D, Chevigné A, Closing the ring: a fourth extracellular loop in chemokine receptors., Sci Signal 2014 Sep; 7(341): pe21.
• 2013
  Santos da Silva E, Mulinge M, Perez Bercoff D, The frantic play of the concealed HIV envelope cytoplasmic tail., Retrovirology 2013 May; 10(): 54.
• 2013
  Mulinge M, Lemaire M, Servais JY, Rybicki A, Struck D, da Silva ES, Verhofstede C, Lie Y, Seguin-Devaux C, Schmit JC, Bercoff DP, HIV-1 tropism determination using a phenotypic Env recombinant viral assay highlights overestimation of CXCR4-usage by genotypic prediction algorithms for CRF01_AE and CRF02_AG [corrected]., PLoS One 2013 ; 8(5): e60566.
• 2012
  Struck D, Wallis CL, Denisov G, Lambert C, Servais JY, Viana RV, Letsoalo E, Bronze M, Aitken SC, Schuurman R, Stevens W, Schmit JC, Rinke de Wit T, Perez Bercoff D, Automated sequence analysis and editing software for HIV drug resistance testing., J Clin Virol 2012 May; 54(1): 30-5.
• 2011
  Baatz F, Struck D, Lemaire M, De Landtsheer S, Servais JY, Arendt V, Schmit JC, Perez Bercoff D, Rescue of HIV-1 long-time archived X4 strains to escape maraviroc., Antiviral Res 2011 Dec; 92(3): 488-92.
• 2011
  Battivelli E, Migraine J, Lecossier D, Matsuoka S, Perez-Bercoff D, Saragosti S, Clavel F, Hance AJ, Modulation of TRIM5alpha activity in human cells by alternatively spliced TRIM5 isoforms., J Virol 2011 Aug; 85(15): 7828-35.
• 2011
  Baatz F, Nijhuis M, Lemaire M, Riedijk M, Wensing AM, Servais JY, van Ham PM, Hoepelman AI, Koopmans PP, Sprenger HG, Devaux C, Schmit JC, Perez Bercoff D, Impact of the HIV-1 env genetic context outside HR1-HR2 on resistance to the fusion inhibitor enfuvirtide and viral infectivity in clinical isolates., PLoS One 2011 ; 6(7): e21535.
• 2010
  Bercoff DP, Triqueneaux P, Lambert C, Oumar AA, Ternes AM, Dao S, Goubau P, Schmit JC, Ruelle J, Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir., Retrovirology 2010 Nov; 7(): 98.
• 2009
  Quercia R, Dam E, Perez-Bercoff D, Clavel F, Selective-advantage profile of human immunodeficiency virus type 1 integrase mutants explains in vivo evolution of raltegravir resistance genotypes., J Virol 2009 Oct; 83(19): 10245-9.
• 2007
  Perez-Bercoff D, Wurtzer S, Compain S, Benech H, Clavel F, Human immunodeficiency virus type 1: resistance to nucleoside analogues and replicative capacity in primary human macrophages., J Virol 2007 May; 81(9): 4540-50.
• 2003
  Truong LX, Luong TT, Scott-Algara D, Versmisse P, David A, Perez-Bercoff D, Nguyen NV, Tran HK, Cao CT, Fontanet A, Follézou JY, Theodorou I, Barré-Sinoussi F, Pancino G, CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam., AIDS 2003 Jul; 17(10): 1425-34.
• 2003
  Hartley O, Dorgham K, Perez-Bercoff D, Cerini F, Heimann A, Gaertner H, Offord RE, Pancino G, Debré P, Gorochov G, Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines., J Virol 2003 Jun; 77(12): 6637-44.
• 2003
  Perez-Bercoff D, David A, Sudry H, Barré-Sinoussi F, Pancino G, Fcgamma receptor-mediated suppression of human immunodeficiency virus type 1 replication in primary human macrophages., J Virol 2003 Apr; 77(7): 4081-94.
• 2002
  Herbein G, Coaquette A, Perez-Bercoff D, Pancino G, Macrophage activation and HIV infection: can the Trojan horse turn into a fortress?, Curr Mol Med 2002 Dec; 2(8): 723-38.